Search - tctmd.com

Displaying 121 - 140 of 179

Sort: Relevancy | Date

News Daily News

SYNTAX at 5 Years: CABG Holds Cost-Effectiveness Edge Over PCI

August 20, 2014

News Daily News

SYNTAX al cabo de 5 Años: CABG es Más Rentable que la PCI

August 20, 2014

News Daily News

5年时SYNTAX：CABG比PCI更具成本效益优势

August 20, 2014

News Daily News

Treatment Delays May Undermine TAVR Efficacy

June 11, 2014

News Daily News

Los Retrasos en el Tratamiento Podrían Minar la Eficacia de la TAVR

June 11, 2014

News Daily News

与华法林或阿司匹林相比，阿哌沙班更具成本效益

Caitlin E. Cox

February 26, 2014

News Daily News

Apixaban es Rentable comparado con Warfarina o Aspirina

Caitlin E. Cox

February 26, 2014

News Daily News

Apixaban Cost-Effective Compared with Warfarin or Aspirin

Caitlin E. Cox

February 26, 2014

News Daily News

荟萃分析：药物治疗基础上联合应用PCI并未改善心肌缺血患者预后

Yael L. Maxwell

December 08, 2013

News Daily News

Meta-analysis: PCI Adds No Benefit to Medical Therapy in Patients with Proven Ischemia

Yael L. Maxwell

December 08, 2013

News Daily News

Meta Análisis: La PCI No añade Beneficio alguno al Tratamiento Médico en Pacientes con Isquemia Demostrada

Yael L. Maxwell

December 08, 2013

News Conference News TCT 2013

SYNTAX Cost-effectiveness Analysis Supports Existing Guidelines

October 29, 2013

News Daily News

Early QOL Advantage of CABG Over PCI for Diabetic Patients Disappears After 2 Years

L.A. McKeown

October 15, 2013

News Daily News

For Inoperable Patients, TAVR Carries Benefits but Raises Lifetime Costs

July 25, 2013

News Daily News

En Pacientes Inoperables, la TAVR produce Beneficios pero Dispara el Gasto de por Vida

July 25, 2013

News Daily News

新型抗凝血剂在心房纤维颤动病患治疗中比华法林抗凝血剂更具性价比(2)

Caitlin E. Cox

May 13, 2013

News Daily News

Novel Anticoagulants Cost-Effective vs. Warfarin in A-fib Patients

Caitlin E. Cox

May 13, 2013

News Daily News

La CABG es Más Rentable a Largo Plazo en Pacientes Diabéticos con Enfermedad Multivaso

Yael L. Maxwell

January 09, 2013

News Daily News

CABG More Cost-Effective in Patients with Diabetes, Multivessel Disease Over Long Term

Yael L. Maxwell

January 09, 2013

News Daily News

Un Modelo Confirma la Rentabilidad de la Denervación Renal en Varones y Mujeres

L.A. McKeown

December 02, 2012

Advertisement

SYNTAX at 5 Years: CABG Holds Cost-Effectiveness Edge Over PCI

SYNTAX al cabo de 5 Años: CABG es Más Rentable que la PCI

5年时SYNTAX：CABG比PCI更具成本效益优势

Treatment Delays May Undermine TAVR Efficacy

Los Retrasos en el Tratamiento Podrían Minar la Eficacia de la TAVR

与华法林或阿司匹林相比，阿哌沙班更具成本效益

Apixaban es Rentable comparado con Warfarina o Aspirina

Apixaban Cost-Effective Compared with Warfarin or Aspirin

荟萃分析：药物治疗基础上联合应用PCI并未改善心肌缺血患者预后

Meta-analysis: PCI Adds No Benefit to Medical Therapy in Patients with Proven Ischemia

Meta Análisis: La PCI No añade Beneficio alguno al Tratamiento Médico en Pacientes con Isquemia Demostrada

SYNTAX Cost-effectiveness Analysis Supports Existing Guidelines

Early QOL Advantage of CABG Over PCI for Diabetic Patients Disappears After 2 Years

For Inoperable Patients, TAVR Carries Benefits but Raises Lifetime Costs

En Pacientes Inoperables, la TAVR produce Beneficios pero Dispara el Gasto de por Vida

新型抗凝血剂在心房纤维颤动病患治疗中比华法林抗凝血剂更具性价比(2)

Novel Anticoagulants Cost-Effective vs. Warfarin in A-fib Patients

La CABG es Más Rentable a Largo Plazo en Pacientes Diabéticos con Enfermedad Multivaso

CABG More Cost-Effective in Patients with Diabetes, Multivessel Disease Over Long Term

Un Modelo Confirma la Rentabilidad de la Denervación Renal en Varones y Mujeres

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content